WeVote
Log In

Bill

Bill

S 2397

CARING for Our Veterans Health Act of 2025

119th Congress Introduced by Angus King and 1 co-sponsor

Bill S 2397 mandates health insurers to cover diagnosis and treatment of uterine fibroids, improving access to care and reducing out-of-pocket costs for affected patients.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 2397

Summary of Bill S 2397

Bill Overview

  • Bill Number: S 2397
  • Title: Requires health insurers to provide coverage for diagnosis and treatment of fibroids
  • Status: Referred to Insurance Committee
  • Introduced On: January 17, 2025
  • Classification: Legislative Bill

Purpose and Intent

The primary purpose of Bill S 2397 is to mandate that health insurance providers offer coverage for the diagnosis and treatment of uterine fibroids. Uterine fibroids are non-cancerous growths in the uterus that can lead to significant health issues, including severe pain, heavy menstrual bleeding, and complications during pregnancy. This bill aims to improve access to necessary medical care for individuals affected by this condition.

Key Provisions

  • Coverage Requirement: The bill stipulates that health insurers must cover all medically necessary services related to the diagnosis and treatment of fibroids. This includes, but is not limited to:

    • Diagnostic imaging (e.g., ultrasounds, MRIs)
    • Surgical procedures (e.g., myomectomy, hysterectomy)
    • Non-surgical treatments (e.g., medication, uterine artery embolization)

  • Patient Education: Insurers may also be required to provide educational resources to patients regarding the nature of fibroids, treatment options, and potential outcomes.

Affected Parties

  • Patients: Individuals diagnosed with fibroids will benefit from improved access to necessary treatments without the burden of high out-of-pocket costs.
  • Health Insurers: Insurance companies will need to adjust their policies and coverage plans to comply with the new requirements set forth by this bill.
  • Healthcare Providers: Medical professionals involved in the diagnosis and treatment of fibroids will need to stay informed about the coverage options available to their patients.

Procedural Aspects

  • The bill was introduced on January 17, 2025, and has been referred to the Insurance Committee for further consideration. The timeline for subsequent actions, such as hearings or votes, will depend on the committee's schedule and legislative priorities.

Related Legislation

  • S 8549 (prior-session): A related bill from a previous session that may have addressed similar issues regarding fibroid treatment coverage.
  • S 1194 (prior-session): Another prior-session bill that could provide context or background on legislative efforts related to fibroids.
  • A 5830 (companion bill): A companion bill in the Assembly that mirrors the provisions of S 2397, indicating a broader legislative push for this issue.

Conclusion

Bill S 2397 represents a significant step toward ensuring that individuals suffering from uterine fibroids receive the necessary medical care without financial hardship. By mandating insurance coverage for diagnosis and treatment, the bill aims to enhance the quality of life for many patients and address a critical healthcare need.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.